Johnson & Johnson Eulerpool Vijesti

Johnson & Johnson Aktie News

Johnson & Johnson prate mnogi novinari i investitori širom svijeta. Najnovije Johnson & Johnson vijesti prikupljamo ovdje.

• 8. siječnja ·

  SeekingAlpha
  VOOV: S&P 500 Value Over Growth In 2025, Solid Macro Backdrop
• 7. siječnja ·

  SeekingAlpha
  Johnson & Johnson: A Potential Beneficiary Of A Great Rotation
• 7. siječnja ·

  Yahoo
  J&J Says Lung Cancer Combo Improves Survival More Than Standard of Care
• 7. siječnja ·

  SeekingAlpha
  Top 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4)
• 7. siječnja ·

  SeekingAlpha
  Buy 1 January S&P 500 Dividend Aristocrat Out Of 38 'Safer'
• 7. siječnja ·

  Yahoo
  RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show statistically significant and clinically meaningful improvement in overall survival versus osimertinib
• 7. siječnja ·

  SeekingAlpha
  Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)
• 7. siječnja ·

  SeekingAlpha
  Johnson & Johnson: I'm Saying Yes To This Mess
• 7. siječnja ·

  Yahoo
  Subcutaneous options offer convenience for patients — and a valuable window for drugmakers
• 6. siječnja ·

  SeekingAlpha
  My Top 10 Dividend-Paying Buy-And-Hold Stocks For 2025